Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
In this study it is intended to compare the blood pressure lowering effect of the combination
of candesartan cilexetil (candesartan) 32 mg and hydrochlorothiazide (HCT) 25 mg and the
combination of candesartan 32 mg and HCT 12.5 mg to that of candesartan 32 mg alone in
patients whose blood pressure is not well controlled on candesartan 32 mg monotherapy. The
Primary Objectives are to compare sitting BP lowering effect of candesartan/HCT 32/25 mg and
candesartan/HCT 32/12.5 mg with that of candesartan 32 mg, respectively.